Allison Wheeler

May 5, 2022

COVID-associated bleeding risk

While case reports have noted acquired hemophilia after COVID-19 infection or vaccination, a new study finds no increased risk.

By Leigh MacMillan
May 26, 2021

Predicting blood clots before they happen in pediatric patients

Monroe Carell Jr. Children’s Hospital at Vanderbilt has launched a study to determine the impact of a predictive model for identifying pediatric patients at risk for developing blood clots or venous thromboembolisms (VTEs).

By Jessica Pasley
May 12, 2021

Heparin, platelets discouraged as treatment for blood clots after COVID vaccine

Heparin and platelets are discouraged as treatment for patients who develop blood clots in the brain and low platelet counts 6-15 days after receiving Johnson & Johnson’s Janssen COVID-19 vaccine, following a clinical investigation review of 12 U.S. cases conducted by the CDC and institutions including Vanderbilt University Medical Center.

By Craig Boerner
April 14, 2020

VUMC seeks plasma donations from recovered COVID-19 patients

Vanderbilt University Medical Center is recruiting volunteers who have tested positive for COVID-19 and fully recovered to donate plasma to help those who are currently ill with the virus as part of a new research study.

By VUMC News and Communications
September 8, 2016

Collaborative clinic focuses on bleeding disorders

Vanderbilt University Medical Center (VUMC) is home to a specialized clinic for teens, adolescents and young adults focusing on bleeding disorders.

By Jessica Pasley